GHP Investment Advisors Inc. Sells 153 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

GHP Investment Advisors Inc. lowered its holdings in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 0.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 54,563 shares of the company’s stock after selling 153 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Henry Schein were worth $3,978,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Cromwell Holdings LLC increased its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC bought a new position in shares of Henry Schein in the 2nd quarter worth $31,000. Beach Investment Counsel Inc. PA bought a new position in shares of Henry Schein in the 2nd quarter worth $37,000. Blue Trust Inc. lifted its stake in shares of Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Finally, Mather Group LLC. boosted its position in Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.14% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HSIC has been the subject of several analyst reports. JPMorgan Chase & Co. decreased their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Robert W. Baird cut their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Barrington Research reiterated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Finally, Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $77.50.

Get Our Latest Stock Report on HSIC

Henry Schein Trading Down 1.2 %

Shares of NASDAQ:HSIC opened at $70.00 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The stock has a market cap of $8.87 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 2.00 and a beta of 0.86. The business has a 50-day moving average price of $70.57 and a 200-day moving average price of $69.80.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. Henry Schein’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the firm posted $1.31 EPS. Equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.